Editorial |

Latent Tuberculosis Needs Attention

Dwight A. Powell, MD
Arch Pediatr Adolesc Med. 2008;162(5):489-490. doi:10.1001/archpedi.162.5.489.
Text Size: A A A
Published online


Tuberculosis (TB) is one of the most common infections in the world. It is estimated that one-third of the world's population is currently infected with TB.1 The majority of those infected have latent tuberculosis (LTBI). Following infection with Mycobacterium tuberculosis (MTB), the organism replicates, most commonly in the lung as the portal of entry, then spreads through lymphatics to the blood stream where virtually any organ in the body can become infected. By the time this has occurred (2-3 months after infection) the host immune response develops in 95% of otherwise healthy persons and sets up granulomas that wall off the MTB organisms wherever they have settled. Many of these organisms remain viable in a dormant or latent state with the potential to reactivate at a later date when the immune system may weaken. The percentage of otherwise healthy persons who eventually reactivate varies from 5% to 15%; the younger the age at initial infection, the higher the risk of reactivation.2 Latent tuberculosis can be effectively treated with a completed course of therapy with either isoniazid or rifampin. Therefore, the Centers for Disease Control and Prevention and the American Thoracic Society have designated the identification and treatment of patients with LTBI as one of the major goals in eliminating TB from the United States.3 It is estimated that 10 to 15 million persons in the United States currently have LTBI.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles